ABEL [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2014-11-19 17:59 (4236 d 02:38 ago) – Posting: # 13887
Views: 16,308

Hi nobody,

❝ Why not interchangeable when MA was granted based on BE-studies for at least one formulation? Could you provide some details on the reasons?


This particular one was BE to Concerta and no clinical studies were performed. The other products stand on their own (clinical data) and these two papers show lack of BE between them.

❝ PS: Found somefink interesting, a strange company called BEBAC has apparently been digging deep into methylphenidate in the past...


Well yes, though I didn’t support Hexal in this project. ;-) My presentations are licensed [image] and they quoted the source correctly. But they used it for com­mer­cial pur­poses (violating the license). Shall I sue them?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
159 visitors (0 registered, 159 guests [including 28 identified bots]).
Forum time: 21:37 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5